S&P 500   3,897.80 (+2.27%)
DOW   31,619.08 (+2.22%)
QQQ   321.30 (+2.28%)
AAPL   125.64 (+3.61%)
MSFT   236.41 (+1.73%)
FB   261.39 (+1.46%)
GOOGL   2,059.63 (+1.87%)
TSLA   711.97 (+5.40%)
AMZN   3,124.66 (+1.03%)
NVDA   546.54 (-0.37%)
BABA   239.79 (+0.85%)
CGC   34.89 (+6.53%)
GE   13.15 (+4.86%)
MU   93.88 (+2.57%)
NIO   49.42 (+7.95%)
AMD   85.19 (+0.80%)
T   28.20 (+1.11%)
F   11.96 (+2.22%)
ACB   11.24 (+6.84%)
DIS   195.68 (+3.51%)
BA   224.50 (+5.89%)
NFLX   549.16 (+1.91%)
BAC   35.68 (+2.79%)
S&P 500   3,897.80 (+2.27%)
DOW   31,619.08 (+2.22%)
QQQ   321.30 (+2.28%)
AAPL   125.64 (+3.61%)
MSFT   236.41 (+1.73%)
FB   261.39 (+1.46%)
GOOGL   2,059.63 (+1.87%)
TSLA   711.97 (+5.40%)
AMZN   3,124.66 (+1.03%)
NVDA   546.54 (-0.37%)
BABA   239.79 (+0.85%)
CGC   34.89 (+6.53%)
GE   13.15 (+4.86%)
MU   93.88 (+2.57%)
NIO   49.42 (+7.95%)
AMD   85.19 (+0.80%)
T   28.20 (+1.11%)
F   11.96 (+2.22%)
ACB   11.24 (+6.84%)
DIS   195.68 (+3.51%)
BA   224.50 (+5.89%)
NFLX   549.16 (+1.91%)
BAC   35.68 (+2.79%)
S&P 500   3,897.80 (+2.27%)
DOW   31,619.08 (+2.22%)
QQQ   321.30 (+2.28%)
AAPL   125.64 (+3.61%)
MSFT   236.41 (+1.73%)
FB   261.39 (+1.46%)
GOOGL   2,059.63 (+1.87%)
TSLA   711.97 (+5.40%)
AMZN   3,124.66 (+1.03%)
NVDA   546.54 (-0.37%)
BABA   239.79 (+0.85%)
CGC   34.89 (+6.53%)
GE   13.15 (+4.86%)
MU   93.88 (+2.57%)
NIO   49.42 (+7.95%)
AMD   85.19 (+0.80%)
T   28.20 (+1.11%)
F   11.96 (+2.22%)
ACB   11.24 (+6.84%)
DIS   195.68 (+3.51%)
BA   224.50 (+5.89%)
NFLX   549.16 (+1.91%)
BAC   35.68 (+2.79%)
S&P 500   3,897.80 (+2.27%)
DOW   31,619.08 (+2.22%)
QQQ   321.30 (+2.28%)
AAPL   125.64 (+3.61%)
MSFT   236.41 (+1.73%)
FB   261.39 (+1.46%)
GOOGL   2,059.63 (+1.87%)
TSLA   711.97 (+5.40%)
AMZN   3,124.66 (+1.03%)
NVDA   546.54 (-0.37%)
BABA   239.79 (+0.85%)
CGC   34.89 (+6.53%)
GE   13.15 (+4.86%)
MU   93.88 (+2.57%)
NIO   49.42 (+7.95%)
AMD   85.19 (+0.80%)
T   28.20 (+1.11%)
F   11.96 (+2.22%)
ACB   11.24 (+6.84%)
DIS   195.68 (+3.51%)
BA   224.50 (+5.89%)
NFLX   549.16 (+1.91%)
BAC   35.68 (+2.79%)
Log in
NYSE:PRGO

Perrigo Stock Forecast, Price & News

$43.38
+3.02 (+7.48 %)
(As of 03/1/2021 11:04 AM ET)
Add
Compare
Today's Range
$39.98
Now: $43.38
$45.30
50-Day Range
$40.78
MA: $43.64
$46.12
52-Week Range
$38.20
Now: $43.38
$58.83
Volume104,332 shs
Average Volume1.56 million shs
Market Capitalization$5.92 billion
P/E RatioN/A
Dividend Yield2.23%
Beta1.18
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals segments. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the brand names of Prevacid, 24HR, Good Sense, Zephrex D, ScarAway, Plackers, and Rembrandt. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands and consumer focused products through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 30 countries, primarily in Europe. The Prescription Pharmaceuticals segment develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, controlled substances, injectable, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Perrigo logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
CUSIP71429010
Phone353-1709-4000
Employees11,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.84 billion
Cash Flow$6.50 per share
Book Value$42.64 per share

Profitability

Net Income$146.10 million

Miscellaneous

Market Cap$5.92 billion
Next Earnings Date3/1/2021 (Confirmed)
OptionableOptionable

MarketRank

Overall MarketRank

2.55 out of 5 stars

Medical Sector

11th out of 1,962 stocks

Pharmaceutical Preparations Industry

5th out of 772 stocks

Analyst Opinion: 3.2Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -
$43.38
+3.02 (+7.48 %)
(As of 03/1/2021 11:04 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRGO News and Ratings via Email

Sign-up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Perrigo (NYSE:PRGO) Frequently Asked Questions

Is Perrigo a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Perrigo stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PRGO, but not buy additional shares or sell existing shares.
View analyst ratings for Perrigo
or view top-rated stocks.

What stocks does MarketBeat like better than Perrigo?

Wall Street analysts have given Perrigo a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Perrigo wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Perrigo?

Perrigo saw a increase in short interest in January. As of January 15th, there was short interest totaling 5,560,000 shares, an increase of 29.3% from the December 31st total of 4,300,000 shares. Based on an average daily volume of 1,070,000 shares, the days-to-cover ratio is presently 5.2 days.
View Perrigo's Short Interest
.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for Perrigo
.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) released its quarterly earnings data on Monday, March, 1st. The company reported $0.93 earnings per share for the quarter, missing the Zacks' consensus estimate of $1.00 by $0.07. The firm earned $1.30 billion during the quarter, compared to the consensus estimate of $1.33 billion. Perrigo had a negative net margin of 0.13% and a positive trailing twelve-month return on equity of 9.78%. The firm's revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.06 EPS.
View Perrigo's earnings history
.

How has Perrigo's stock price been impacted by Coronavirus (COVID-19)?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PRGO stock has decreased by 7.7% and is now trading at $42.49.
View which stocks have been most impacted by COVID-19
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Tuesday, February 23rd. Stockholders of record on Friday, March 12th will be paid a dividend of $0.24 per share on Tuesday, March 30th. This represents a $0.96 annualized dividend and a yield of 2.26%. The ex-dividend date is Thursday, March 11th. This is a positive change from Perrigo's previous quarterly dividend of $0.23.
View Perrigo's dividend history
.

Is Perrigo a good dividend stock?

Perrigo pays an annual dividend of $0.90 per share and currently has a dividend yield of 2.23%. The dividend payout ratio of Perrigo is 22.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Perrigo will have a dividend payout ratio of 20.88% next year. This indicates that Perrigo will be able to sustain or increase its dividend.
View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY 2021 Pre-Market earnings guidance on Monday, March, 1st. The company provided earnings per share guidance of 2.50-2.70 for the period.

What price target have analysts set for PRGO?

6 analysts have issued 12 month target prices for Perrigo's shares. Their forecasts range from $49.00 to $63.00. On average, they anticipate Perrigo's share price to reach $54.20 in the next year. This suggests a possible upside of 27.6% from the stock's current price.
View analysts' price targets for Perrigo
or view top-rated stocks among Wall Street analysts.

Who are Perrigo's key executives?

Perrigo's management team includes the following people:
  • Mr. Murray S. Kessler, CEO, Pres & Director (Age 61, Pay $3.06M)
  • Mr. Raymond P. Silcock, CFO, Principal Accounting Officer & Exec. VP (Age 70, Pay $1.48M)
  • Mr. James E. Dillard III, Exec. VP & Chief Scientific Officer (Age 57, Pay $1.01M)
  • Mr. Svend Andersen, Exec. VP & Pres of Consumer Healthcare International (Age 59, Pay $1.08M)
  • Mr. Ronald C. Janish, Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain (Age 55)
  • Mr. Shannon Hukill, Sr. Director of Technical Operations
  • Mr. Thomas M. Farrington, Chief Information Officer & Exec. VP (Age 64)
  • Mr. Bradley Joseph, VP of Global Investor Relations & Corp. Communications
  • Mr. Todd W. Kingma, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Ms. Mary Reilly-Brest, Director of Global Organizational and Human Resource Devel.

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo CEO Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among Perrigo's employees.

Who are some of Perrigo's key competitors?

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (12.88%), BlackRock Inc. (7.40%), Dimensional Fund Advisors LP (2.11%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (1.77%), Sound Shore Management Inc. CT (1.61%) and Northern Trust Corp (1.11%). Company insiders that own Perrigo stock include Grainne Quinn, Richard S Sorota, Ronald Craig Janish, Ronald Winowiecki, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo
.

Which institutional investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Alliancebernstein L.P., Price T Rowe Associates Inc. MD, State of Wisconsin Investment Board, Diamond Hill Capital Management Inc., Amundi Pioneer Asset Management Inc., Northern Trust Corp, and BlackRock Inc..
View insider buying and selling activity for Perrigo
or view top insider-selling stocks.

Which institutional investors are buying Perrigo stock?

PRGO stock was bought by a variety of institutional investors in the last quarter, including Harel Insurance Investments & Financial Services Ltd., SummerHaven Investment Management LLC, Phoenix Holdings Ltd., Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management, First Trust Advisors LP, Renaissance Technologies LLC, Sasco Capital Inc. CT, and M.D. Sass Investors Services Inc.. Company insiders that have bought Perrigo stock in the last two years include Richard S Sorota, Svend Andersen, and Theodore R Samuels II.
View insider buying and selling activity for Perrigo
or or view top insider-buying stocks.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $42.49.

How much money does Perrigo make?

Perrigo has a market capitalization of $5.80 billion and generates $4.84 billion in revenue each year. The company earns $146.10 million in net income (profit) each year or $4.03 on an earnings per share basis.

How many employees does Perrigo have?

Perrigo employs 11,000 workers across the globe.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

Where are Perrigo's headquarters?

Perrigo is headquartered at THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.